Fast, low-cost, and effective sepsis diagnostic assay
Accurate and comprehensive detection of pathogen and host markers for personalized patient care based on real-time PCR technology
Sepsis, a health emergency kills over 350,000 people every year in the US
It is the #1 cause of death in US hospitals, of which 80% are preventable
Industry experienced personnel committed to innovation
A team comprising of over 150+ years of working in the field
Artificial Intelligence (AI) and Machine Learning (ML) tool to support clinical decisions
POC Verified with ensemble of the three machine learning models - Coming soon!

Products & Services

Sepsis Diagnostic Test Kits

As this ground-breaking diagnostic kit nears its development stage, its impact will be far-reaching, promising to revolutionize the field of infection diagnosis and treatment decision support. By expediting accurate diagnosis, tailoring treatments to individual patients, and optimizing antimicrobial usage, this novel technology holds the potential to save lives, improve patient care, and contribute to the global fight against antibiotic resistance.

Technical Support for Labs & Clinicians

Delphine Diagnostics is developing an app incorporating machine learning algorithms to empower clinicians with real-time decision support. By leveraging a vast database of patient information, treatment guidelines, and clinical outcomes, the kit’s intelligent software will aid healthcare providers in selecting the most appropriate antimicrobial regimen, dosage, and duration. This personalized approach enhances the efficacy of treatment, reduces the likelihood of adverse events, and ultimately improves patient outcomes.

Partners and Allies

Vision icon


Delphine Diagnostics Inc.

Our vision is to enhance human healthcare by engaging in the development and supply of best-in-class, affordable products for diagnosis and treatment.



Delphine Diagnostics, a New Jersey-based startup, is passionate in its efforts to deliver top-tier diagnostic products and supplemental data insights capabilities to speed effective diagnosis and treatment for patients with infectious diseases. The affordability and reliability of our innovative products guide our journey.

Strategic Intent

Delphine Diagnostics, as a forward-thinking medical diagnostics enterprise, aims to manufacture and supply certified testing kits to approved facilities, complemented by advanced AI/ML software applications. Our strategy involves integrating these intelligent technologies to enhance data analysis and diagnostic accuracy, all while adhering to global best practices. This approach not only elevates the standard of our testing kits but also positions us at the forefront of technological innovation in healthcare diagnostics.


As part of augmenting our service to the healthcare needs of patients, service providers (payers), and healthcare providers, our enterprise is planning:

The enterprise team is led by domain and business experts with service and ethical mindsets, across disciplines ranging from Biomedical Science (Pathology, Microbiology, Molecular Biology, and Biochemistry), Data Analytics, and Market development.